Skip to content
Forest Global Training Partners
Home Services AI Governance AI Risk Encyclopedia Contact Us
AI Risk Encyclopedia AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. Discovery of TYR inhibitors from de novo molecular…

AI Risks June 20, 2026 · Science

Discovery of TYR inhibitors from de novo molecular generation to dual-track lead optimization

... Advances Science ImmunologyScience RoboticsScience SignalingScience ... Zhejiang Angel Medical AI Technology Co., Ltd., Hangzhou 311103, PR China .

Read the original at Science ↗

Topics
China & GeopoliticsHealthcareManufacturing & Robotics
Mentions
China
Tracked via
“chinese ai advances”

Related articles

  • Hong Kong issues dual-track policy for AI adoption in finance - Cointelegraph AI Risks · Oct 28, 2024
  • ApoC3 Inhibitors Show Efficacy in Lowering Triglycerides and Reducing Cardiovascular ... AI Risks · Jun 01, 2025
  • International youths experience advanced technology in Zhejiang - CGTN AI Risks · May 12, 2025
  • Chai Discovery scores $70M for de novo antibody design | Mobi Health News AI Use Cases · Aug 08, 2025
  • Novo Nordisk's CEO Ousted: Deep-Value Opportunity With Sentiment Risks - Seeking Alpha AI Risks · May 17, 2025

AI Risk Encyclopedia is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact